CTGCT
  • en
    • si
  • About us
    • About CTGCT
    • Partners
    • CTGCT Day 2026
    • Funding of the CTGCT
  • Job Openings
  • Products and Services
  • Learning Box
    • Learning Box
    • CTGCT Science Talks
    • Publications
  • CTGCT Days 2025
  • POSTS
    • Events
    • Articles
    • News
    • All posts
  • Get in touch

Pacients

  • Events
  • Pacients
  • Business Model
  • Investment
  • CTGCT
  • NIC
  • Rodrigo Ortiz
13 March 2025 Event Date: 12 March 2025 do: 12 March 2025 •

Prime Minister of Slovenia Dr. Robert Golob visits the Kemijski Inštitut to discuss the CTGCT plans

Yesterday, Dr. Robert Golob, Prime Minister of the Slovenian Government, visited the Kemijski inštitut - National Institute of Chemistry.

Pxl 20250313 084506170.mp
  • Articles
  • Pacients
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Economics
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
28 February 2025

How Patient Advocacy is Driving Breakthroughs to Treat CTNNB1 Syndrome

Imagine a world where a child’s genetic disorder, once considered untreatable, is finally on a path toward real solutions. For families affected by the CTNNB1 syndrome, that future is becoming a reality thanks to ...

Paving The Way Ctnnb1
  • Articles
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
25 February 2025

Controlling Cells With Chemically Switchable Antibodies: A New Opportunity For Precision Therapy

Imagine being able to turn a cell’s behavior ON or OFF, just like flipping a light switch. That’s exactly what scientists have achieved with the innovative technology presented in this paper published in the ...

Graphical Abstract Controlling Cells
  • Articles
  • Pacients
  • CTGCT
  • Gregor Cuzak
18 February 2025

Hugs for rare

The 28th of February is approaching which is the Day of Rare diseases. Hugs are being collected in 7 countries to raise awareness of the importance of everyone working together to defeat rare diseases.

Hugs1
  • Articles
  • Pacients
  • Research
  • CTGCT
11 February 2025

Women at CTGCT: Voices from the Lab

Today we we celebrate the International Day of Women and Girls in Science, we take a moment to spotlight the women working at the Centre for the Technologies of Gene and Cell Therapy (CTGCT)

Women In Science Cover, image generated using AI, Dall-e
  • Articles
  • Pacients
  • Researchers
  • Gen Therapy
  • Laboratory
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
28 January 2025

The research on combining cytokines with pyroptosis is gaining widespread media coverage

Research on combining cytokines and pyroptosis for cancer therapy by Slovenian scientists has gained significant media recognition, including TV features, articles, and the honor of being named "Names of the Week".

Odmevi Sara N Iva
  • Media Releases
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Economics
  • Research
  • CTGCT
  • NIC
  • Gregor Cuzak
22 January 2025

Slovenia Joins ERDERA to Advance Rare Disease Research and Collaboration

CTGCT welcomes Slovenia's entry into the European Research Partnership for Rare Diseases ERDERA

Erdera
  • Media Releases
  • Pacients
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
10 January 2025

Head of CTGCT research selected as breakthrough discovery by the national TV in Slovenia

Check this video were he Head of the #CTGCT prof. dr. Mojca Benčina appeared in the news of the Slovenian national TV since her researched was selected as one of the breakthrough discoveries by ...

Mojca Rtve1 Discover Of The Year 2024
  • Articles
  • Clinicians
  • Pacients
  • Cell therapy
  • Gen Therapy
  • Laboratory
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
7 January 2025

Combining cytokines and pyroptosis, a promising weapon against cancer

A recent study published in Nature Communications has unveiled a groundbreaking approach that combines the power of cytokines with a type of cell death called pyroptosis to boost the immune system's ability to fight ...

Cytokine Pyroptosis
  • Latest
  • Media Releases
  • Clinicians
  • Pacients
  • Researchers
  • Research
  • CTGCT
  • Rodrigo Ortiz
  • Rodrigo Ortiz
11 December 2024

CTGCT Newsletter, 1st year in review

Welcome to the first CTGCT Newsletter featuring a selection of the articles we're most proud of in the last year.

  • Articles
  • Pacients
  • Gen Therapy
  • Drug Discovery
  • Laboratory
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
22 November 2024

MyD88 balances cell homeostasis by regulating immune response, mitochondrial function and cell death

A recent study by researchers in the CTGCT investigates the role of the MyD88 protein, a key player in innate immune signaling pathways.

Myd88 Blogpost Cover
  • Events
  • Clinicians
  • Pacients
  • Researchers
  • Investment
  • Raziskave
  • Regulation
  • Charite Berlin
  • CTGCT
  • NIC
  • NIC
  • UCL
  • UMCUtrecht
  • Rodrigo Ortiz
25 October 2024 Event Date: 16 October 2024 do: 19 October 2024 •

Review of CTGCT Conference 2024

From the 16th of October 2024 to the 18th the Kemijski Inštitut hosted the 1st CTGCT Conference

Posts pagination

1 2 3 4

Logo Foot

Center for the Technologies of Gene and Cell Therapies (CTGCT) is an infrastructure center  within the National Institute of Chemistry, Slovenia

Contact

  • +386 1 4760 335
  • info@ctgct.si
  • Hajdrihova 19, 1001 Ljubljana

Privacy policy

  • Cookies

Follow us

X Twitter Brands SolidX-twitter

LinkedIn

Bluesky Brands Solid Bluesky

Funding

 

Eu Logo

Ukri Logo

Ifeelslovenia Logo 400

Project: 101059842 – CTGCT – HORIZON-WIDERA-
Co-funded by the European Union, this project has received funding from Horizon Europe (grant agreement No. 101059842) and European Regional Development Fund EU under Slovenia’s Cohesion Policy Programme 2021-2027 (grant agreement No. C3360-25-952005) and the UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee (grant number 10069462). Views and opinions expressed are of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Commission nor the granting authority can be held responsible for them.


CTGCT © 2026
Website production: Kreativna tovarna